Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
ENDRA Life Sciences Inc. (NDRA) had Stock-Based Compensation of $0.32M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.60M |
|
-- |
|
-- |
|
$1.37M |
|
$-1.37M |
|
$-0.23M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.37M |
|
$-1.33M |
|
0.76M |
|
0.76M |
|
$-2.10 |
|
$-2.10 |
|
| Balance Sheet Financials | |
$1.05M |
|
$0.05M |
|
$0.92M |
|
$1.96M |
|
$0.80M |
|
-- |
|
$0.99M |
|
$1.79M |
|
$0.17M |
|
$0.17M |
|
$0.17M |
|
0.79M |
|
| Cash Flow Statement Financials | |
$-3.57M |
|
$-0.02M |
|
$1.15M |
|
$3.23M |
|
$0.79M |
|
$-2.44M |
|
|
Stock-Based Compensation |
$0.32M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-931.24% |
|
-931.24% |
|
-81.26% |
|
-931.24% |
|
$0.22 |
|
$-4.71 |
|
$-4.69 |
|